Literature DB >> 12676647

Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs.

Mary C Sugden1, Mark J Holness.   

Abstract

The mitochondrial pyruvate dehydrogenase complex (PDC) catalyzes the oxidative decarboxylation of pyruvate, linking glycolysis to the tricarboxylic acid cycle and fatty acid (FA) synthesis. Knowledge of the mechanisms that regulate PDC activity is important, because PDC inactivation is crucial for glucose conservation when glucose is scarce, whereas adequate PDC activity is required to allow both ATP and FA production from glucose. The mechanisms that control mammalian PDC activity include its phosphorylation (inactivation) by a family of pyruvate dehydrogenase kinases (PDKs 1-4) and its dephosphorylation (activation, reactivation) by the pyruvate dehydrogenase phosphate phosphatases (PDPs 1 and 2). Isoform-specific differences in kinetic parameters, regulation, and phosphorylation site specificity of the PDKs introduce variations in the regulation of PDC activity in differing endocrine and metabolic states. In this review, we summarize recent significant advances in our knowledge of the mechanisms regulating PDC with emphasis on the PDKs, in particular PDK4, whose expression is linked with sustained changes in tissue lipid handling and which may represent an attractive target for pharmacological interventions aimed at modulating whole body glucose, lipid, and lactate homeostasis in disease states.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676647     DOI: 10.1152/ajpendo.00526.2002

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  174 in total

Review 1.  The pyruvate carboxylase-pyruvate dehydrogenase axis in islet pyruvate metabolism: Going round in circles?

Authors:  Mary C Sugden; Mark J Holness
Journal:  Islets       Date:  2011-11-01       Impact factor: 2.694

2.  Orphan nuclear receptor estrogen-related receptor γ (ERRγ) is key regulator of hepatic gluconeogenesis.

Authors:  Don-Kyu Kim; Dongryeol Ryu; Minseob Koh; Min-Woo Lee; Donghyun Lim; Min-Jung Kim; Yong-Hoon Kim; Won-Jea Cho; Chul-Ho Lee; Seung Bum Park; Seung-Hoi Koo; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

Review 3.  PGC-1alpha-mediated adaptations in skeletal muscle.

Authors:  Jesper Olesen; Kristian Kiilerich; Henriette Pilegaard
Journal:  Pflugers Arch       Date:  2010-04-19       Impact factor: 3.657

4.  Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction.

Authors:  Xue Xue; Song You; Qiang Zhang; Yan Wu; Guo-Zhang Zou; Paul C Wang; Yu-Liang Zhao; Yan Xu; Lee Jia; Xiaoning Zhang; Xing-Jie Liang
Journal:  Mol Pharm       Date:  2012-02-13       Impact factor: 4.939

5.  Two dichloric compounds inhibit in vivo U87 xenograft tumor growth.

Authors:  Dmitriy Ovcharenko; Catrina Chitjian; Alex Kashkin; Alex Fanelli; Victor Ovcharenko
Journal:  Cancer Biol Ther       Date:  2019-06-24       Impact factor: 4.742

6.  CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/beta-mediated adaptation to metabolic stress.

Authors:  Zaher Nahlé; Michael Hsieh; Terri Pietka; Chris T Coburn; Paul A Grimaldi; Michael Q Zhang; Debopriya Das; Nada A Abumrad
Journal:  J Biol Chem       Date:  2008-02-28       Impact factor: 5.157

7.  Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart.

Authors:  Sihem Boudina; Heiko Bugger; Sandra Sena; Brian T O'Neill; Vlad G Zaha; Olesya Ilkun; Jordan J Wright; Pradip K Mazumder; Eric Palfreyman; Timothy J Tidwell; Heather Theobald; Oleh Khalimonchuk; Benjamin Wayment; Xiaoming Sheng; Kenneth J Rodnick; Ryan Centini; Dong Chen; Sheldon E Litwin; Bart E Weimer; E Dale Abel
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

8.  TGR5 activation induces cytoprotective changes in the heart and improves myocardial adaptability to physiologic, inotropic, and pressure-induced stress in mice.

Authors:  Zeena Eblimit; Sundararajah Thevananther; Saul J Karpen; Heinrich Taegtmeyer; David D Moore; Luciano Adorini; Daniel J Penny; Moreshwar S Desai
Journal:  Cardiovasc Ther       Date:  2018-08-22       Impact factor: 3.023

9.  Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding.

Authors:  Jordan J Wright; Jaetaek Kim; Jonathan Buchanan; Sihem Boudina; Sandra Sena; Kyriaki Bakirtzi; Olesya Ilkun; Heather A Theobald; Robert C Cooksey; Kostantin V Kandror; E Dale Abel
Journal:  Cardiovasc Res       Date:  2009-01-15       Impact factor: 10.787

10.  FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate.

Authors:  Lin Piao; Vaninder K Sidhu; Yong-Hu Fang; John J Ryan; Kishan S Parikh; Zhigang Hong; Peter T Toth; Erik Morrow; Shelby Kutty; Gary D Lopaschuk; Stephen L Archer
Journal:  J Mol Med (Berl)       Date:  2012-12-18       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.